Clinical Trial Update: Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors

View source ↗

Summary

This clinical trial update reports on the risk of psychopathology and neurocognitive impairment among survivors of acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Neurocognitive Impairment, Acute Lymphoblastic Leukemia | Status: COMPLETED